相似文献
1
[The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):95-99. doi: 10.3760/cma.j.issn.1001-0939.2020.02.006.
2
[Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer].
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):87-91. doi: 10.3760/cma.j.issn.1001-0939.2020.02.004.
3
Recent clinical trials of immunotherapy in non-small-cell lung cancer.
Immunotherapy. 2019 Apr;11(6):461-466. doi: 10.2217/imt-2019-0021.
4
The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
Future Oncol. 2018 Feb;14(3):191-194. doi: 10.2217/fon-2017-0124. Epub 2018 Jan 16.
5
Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors.
Oncologist. 2019 Feb;24(Suppl 1):S21-S30. doi: 10.1634/theoncologist.2019-IO-S1-s02.
6
[Immuno-checkpoint inhibitor resistance and strategy in lung cancer].
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jul 12;43(7):603-606. doi: 10.3760/cma.j.cn112147-20200312-00319.
7
The estrogen pathway as a modulator of response to immunotherapy.
Immunotherapy. 2019 Sep;11(13):1161-1176. doi: 10.2217/imt-2019-0024. Epub 2019 Jul 30.
8
Principles of Immunotherapy in Non-Small Cell Lung Cancer.
Thorac Surg Clin. 2020 May;30(2):187-198. doi: 10.1016/j.thorsurg.2020.01.009.
9
Advances in evidence-based medicine for immunotherapy of non-small cell lung cancer.
J Evid Based Med. 2018 Nov;11(4):278-287. doi: 10.1111/jebm.12322. Epub 2018 Nov 16.
10
Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?
Curr Probl Cancer. 2019 Feb;43(1):43-53. doi: 10.1016/j.currproblcancer.2018.07.008. Epub 2018 Aug 4.
Zotero 插件